Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells

Title: The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells
Authors: Di Muro, Genesio; Catalano, Rosa; Treppiedi, Donatella; Barbieri, Anna Maria; Mangili, Federica; Marra, Giusy; Di Bari, Sonia; Esposito, Emanuela; Nozza, Emma; Lania, Andrea G.; Ferrante, Emanuele; Locatelli, Marco; Modena, Daniela; Steinkuhler, Christian; Peverelli, Erika; Mantovani, Giovanna
Contributors: G. Di Muro; R. Catalano; D. Treppiedi; A.M. Barbieri; F. Mangili; G. Marra; S. Di Bari; E. Esposito; E. Nozza; A.G. Lania; E. Ferrante; M. Locatelli; D. Modena; C. Steinkuhler; E. Peverelli; G. Mantovani
Publisher Information: MDPI
Publication Year: 2024
Collection: The University of Milan: Archivio Istituzionale della Ricerca (AIR)
Subject Terms: ITF2984; NF-PitNET; SSTRs; Settore MED/46 - Scienze Tecniche di Medicina di Laboratorio; Settore MED/13 - Endocrinologia
Description: Somatostatin receptor ligands (SRLs) with high affinity for somatostatin receptors 2 and 5 (SSTR2 and SSTR5) are poorly efficacious in NF-PitNETs, expressing high levels of SSTR3. ITF2984 is a pan-SSTR ligand with high affinity for SSTR3, able to induce SSTR3 activation and to exert antitumoral activity in the MENX rat model. The aim of this study was to test ITF2984's antiproliferative and proapoptotic effects in NF-PitNET primary cultured cells derived from surgically removed human tumors and to characterize their SSTR expression profile. We treated cells derived from 23 NF-PitNETs with ITF2984, and a subset of them with octreotide, pasireotide (SRLs with high affinity for SSTR2 or 5, respectively), or cabergoline (DRD2 agonist) and we measured cell proliferation and apoptosis. SSTR3, SSTR2, and SSTR5 expression in tumor tissues was analyzed by qRT-PCR and Western blot. We demonstrated that ITF2984 reduced cell proliferation (-40.8 (17.08)%, p < 0.001 vs. basal, n = 19 NF-PitNETs) and increased cell apoptosis (+41.4 (22.1)%, p < 0.001 vs. basal, n = 17 NF-PitNETs) in all tumors tested, whereas the other drugs were only effective in some tumors. In our model, SSTR3 expression levels did not correlate with ITF2984 antiproliferative nor proapoptotic effects. In conclusion, our data support a possible use of ITF2984 in the pharmacological treatment of NF-PitNET.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/38612419; info:eu-repo/semantics/altIdentifier/wos/WOS:001201584400001; volume:25; issue:7; firstpage:1; lastpage:10; numberofpages:10; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/2434/1051095
DOI: 10.3390/ijms25073606
Availability: https://hdl.handle.net/2434/1051095; https://doi.org/10.3390/ijms25073606
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.DAFEFCF4
Database: BASE